Razumab 10mg Injection

Razumab 10mg Injection contains Ranibizumab, which is primarily used in the treatment of certain retinal diseases.   

Brand Name: Razumab

Composition: Ranibizumab

Mechanism of Action:

An anti-VEGF drug called ranibizumab attaches itself to VEGF-A, a protein involved in angiogenesis, the development of new blood vessels, and suppresses it. Ranibizumab helps patients with certain retinal illnesses retain or enhance their vision by blocking VEGF-A, which also lessens the growth of aberrant blood vessels and the leakage from these vessels.

Uses:

• Neovascular (wet) age-related macular degeneration
• Diabetic macular edema
• Macular edema following retinal vein occlusion
• Myopic choroidal neovascularization

Dosage and Administration:

Usually given once a month (every 28 days) as a single intravitreal injection of 0.5 mg (0.05 mL). The particular disease and the patient's reaction determine the precise dosage and frequency. administered by a trained ophthalmologist straight into the eye's vitreous cavity.

Side Effects:

• Nausea
• Vomiting
• Fever
• Headache
• Dizziness
• Swelling
• Diarrhea

Safety Advise:

Liver  

Patients with hepatic impairment may require dose modifications. Throughout treatment, liver function should be routinely assessed. Kindly speak with your healthcare provider.

Kidney  

Patients with renal impairment may require dose modifications. Throughout treatment, kidney function should be routinely assessed. Kindly speak with your healthcare provider.

Pregnancy  

As Ranibizumab may harm the fetus, it is not advised to use it during pregnancy. Kindly speak with your healthcare provider.

Breast Feeding  

Razumab 10mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Kindly speak with your healthcare provider.

Alcohol    

Drinking alcohol while taking Razumab 10mg Injection is not advised. Kindly speak with your healthcare provider.

Storage:

Store the vial at 2°C to 8°C (36°F to 46°F) in a refrigerator. Do not freeze. Protect from light.

How to use this Medication?

Products for ranibizumab injections are available as a liquid solution that a physician can inject into the eye. It is typically administered once a month in a doctor's office. If it is more convenient for you, your doctor may provide your injections at a different time.

 

Additionally, ranibizumab is available as an implant that a physician can place with a needle in a clinic or doctor's office into the white portion of your eye. Every six months, a doctor in a clinic or medical office will need to refill the implant by injecting more fluid into it.

References:

1. Blick SK, Keating GM, Wagstaff AJ. Ranibizumab. Drugs. 2007 Jun;67:1199-206.

2. Narayanan R, Kuppermann BD, Jones C, Kirkpatrick P. Ranibizumab. Nature Reviews Drug Discovery. 2006 Oct 1;5(10).

3. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology. 2007 Dec 1;114(12):2179-82.

4. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. American journal of ophthalmology. 2007 Apr 1;143(4):679-80.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Intas Pharmaceuticals Ltd

Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Country of origin: India

Frequently Asked Questions (FAQs):

1. What is Razumab 10mg Injection?

Razumab 10mg contains Ranibizumab, a monoclonal antibody (anti-VEGF therapy). It may be prescribed for specific eye conditions to potentially prevent vision loss. Strict adherence to an ophthalmologist's care plan is required.

2. How may Razumab work?

It is believed to inhibit the VEGF protein, which may potentially slow the growth of abnormal blood vessels and reduce leakage in the retina.

3. What conditions may it be prescribed for?

It may be considered for wet age-related macular degeneration (AMD), diabetic macular oedema, or macular oedema following retinal vein occlusion.

4. How is it administered?

It is administered as an intravitreal injection (directly into the eye) by a specialized eye doctor in a sterile clinical setting.

5. How often is the injection given?

Treatment often begins with monthly injections, followed by a maintenance schedule determined by your doctor. You must adhere to all scheduled appointments.

6. What are the possible side effects?

Patients may potentially experience eye pain, floaters, increased eye pressure, or temporary blurred vision immediately after the injection.

7. Are there serious risks associated with eye injections?

There is a rare but potential risk of severe eye infection (endophthalmitis) or retinal detachment. Report any sudden increase in pain or vision loss immediately.

8. Is regular monitoring required?

Yes, your ophthalmologist will mandate frequent eye exams and imaging (like OCT) to assess response. You must not skip these check-ups.

9. Can it cure macular degeneration?

It is not a cure. It may potentially halt progression and sometimes improve vision, but long-term adherence to therapy is usually necessary.

10. What post-injection care is needed?

You must adhere to your doctor's instructions regarding avoiding rubbing the eye, using prescribed eye drops, and swimming restrictions.

11. Can I drive after the injection?

Vision may potentially be temporarily impaired. Adhere to advice to arrange for someone to drive you home.

12. Is Razumab a prescription medicine?

Yes, it is a prescription-only medication administered exclusively by an ophthalmologist.

Medical Disclaimer:

Razumab 10mg Injection is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional. Do not self-medicate, alter the dosage, or discontinue use without consulting your doctor. The information provided here is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Individual results, benefits, and risks may vary. Always consult your physician before starting, changing, or stopping any medication.